HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.

Abstract
The aim of this investigation was to compare two current non-invasive modalities, single photon emission tomography (SPECT) using 123-iodine-alpha-methyl tyrosine (123I-IMT) and single-voxel proton magnetic resonance spectroscopy (1H-MRS) at 3.0 T, with regard to their ability to differentiate between residual/ recurrent tumors and treatment-related changes in patients pretreated for glioma. The patient population comprised 25 patients in whom recurrent glioma was suspected based on MR imaging. SPECT imaging started 10 min after iv. injection of 300-370 MBq 123I-IMT and was performed using a triple-head system. The IMT uptake was calculated semiquantitatively using regions-of-interest. 1H-MRS was performed at 3.0 T using the single-volume point-resolved spectroscopy (PRESS) technique. Guided by MR imaging volumes-of-interest for spectroscopy were placed into the suspected lesions. Signal intensities of choline-containing compounds (Cho), creatine and phosphocreatine (Cr), and N-acetylaspartate (NAA) were obtained. When using the cut-off of 1.62 for 123I-IMT uptake, the sensitivity, specificity, and accuracy of the 123I-IMT SPECT were 95, 100 and 96%, respectively. For 1H-MRS, the sensitivity, specificity and accuracy were 89, 83 and 88%, respectively, based both on the metabolic ratios of Cho/Cr and Cho/NAA as tumor criterion with cut-off values of 1.11 and 1.17, respectively. In conclusion, 123I-IMT SPECT yielded more favorable results compared to 1H-MRS at distinguishing recurrent and/or residual glioma from post-therapeutic changes and may be particularly valuable when the evaluation of tumor extent is necessary.
AuthorsMichail Plotkin, Julia Eisenacher, Harald Bruhn, Reinhard Wurm, Roger Michel, Florian Stockhammer, Annelie Feussner, Oliver Dudeck, Peter Wust, Roland Felix, Holger Amthauer
JournalJournal of neuro-oncology (J Neurooncol) Vol. 70 Issue 1 Pg. 49-58 (Oct 2004) ISSN: 0167-594X [Print] United States
PMID15527107 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Iodine Radioisotopes
  • Methyltyrosines
  • Radiopharmaceuticals
  • 3-iodo-alpha-methyltyrosine
  • Creatine
  • Choline
Topics
  • Adult
  • Aged
  • Brain Neoplasms (diagnostic imaging, pathology)
  • Choline (metabolism)
  • Creatine (metabolism)
  • Diagnosis, Differential
  • Female
  • Glioblastoma (diagnostic imaging, pathology)
  • Humans
  • Iodine Radioisotopes
  • Magnetic Resonance Imaging
  • Male
  • Methyltyrosines
  • Middle Aged
  • Neoplasm Recurrence, Local (diagnostic imaging, pathology)
  • Neoplasm, Residual (diagnostic imaging, pathology)
  • Postoperative Period
  • Predictive Value of Tests
  • Prospective Studies
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: